To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes.

3.0.0 2223 2023-01-11T15:47:56Z 2023-01-11T15:47:56Z House H HR 2007-05-08 110 hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2007-05-08T18:28:18Z Referred to 2007-05-08T14:33:10Z 2007-05-08 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2007-05-08 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2007-05-08 Introduced in House IntroReferral Intro-H 9 Library of Congress 2007-05-08 Introduced in House IntroReferral 1000 9 Library of Congress P000589 Rep. Porter, Jon C. [R-NV-3] Jon Porter R NV C. 3 N H001041 Rep. Heller, Dean [R-NV-2] Dean Heller R NV 2 2007-05-08 True M001147 Rep. McCotter, Thaddeus G. [R-MI-11] Thaddeus McCotter R MI G. 11 2007-05-22 False M000933 Rep. Moran, James P. [D-VA-8] JAMES MORAN D VA P. 8 2007-06-18 False L000293 Rep. Lewis, Ron [R-KY-2] RON LEWIS R KY 2 2007-06-26 False C000059 Rep. Calvert, Ken [R-CA-44] KEN CALVERT R CA 44 2008-02-12 False Health Congressional reporting requirements Drugs Environmental Protection Environmental assessment Governmental investigations Pharmacies Refuse and refuse disposal Health

00 2007-05-08 Introduced in House 2007-08-08T18:44:53Z Requires the Director of the Office of National Drug Control Policy to study and report to Congress on prescription drug disposal programs in which individuals return unused prescription drugs to pharmacies or other locations, focusing on certain issues including: (1) best practices of such programs; (2) affects of such programs on pharmacies; and (3) training and infrastructure needed to ensure the success of such programs.

Requires the Administrator of the Environmental Protection Agency (EPA) to conduct a study identifying the environmental impacts of current prescription drug disposal programs and methods.

]]>

To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes. Display Title To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes. Official Title as Introduced To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes. Introduced in House IH Introduced in House 2007-05-08T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-110hr2223ih/xml/BILLS-110hr2223ih.xml 2007-05-08 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.